Fresenius Dali 750 Kit Hemadsorption Device Safety Notice

ANSM Drug & Device Safety Alerts

Published April 7th, 2026

Detected April 7th, 2026

Summary

ANSM issued a safety alert regarding a field safety corrective action conducted by Fresenius Medical Care AG for the Dali 750 Kit hemadsorption device. The safety action is registered under reference R2608923. Users of this medical device have received direct correspondence from Fresenius with details of the corrective measure.

View original document View source feed page

What changed

ANSM published a medical device safety notice informing healthcare facilities and professionals of a safety action taken by Fresenius Medical Care AG concerning the Dali 750 Kit hemadsorption system. The corrective action bears ANSM registration number R2608923, with the manufacturer's detailed letter dated 07/04/2026.

Healthcare providers and medical device users should download the Fresenius correspondence letter from the ANSM website to determine whether their facility is affected by this action. Facilities using the Dali 750 Kit should review the safety information and follow any instructions provided by Fresenius Medical Care AG directly, as ANSM has directed all inquiries to the manufacturer.

What to do next

Download and review the Fresenius Medical Care AG safety letter (PDF dated 07/04/2026)
Identify whether your facility uses or stocks the Dali 750 Kit hemadsorption device
Contact Fresenius Medical Care AG directly for questions and follow any device handling instructions provided

Source document (simplified)

A+ A-

Information n° R2608923 destinée aux pharmacies d'usage intérieur, laboratoires d'analyses de biologie médicale, officines et structures de soins de ville L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectué par la société Fresenius Medical Care AG.

Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2608923. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Téléchargez le courrier de la société Fresenius Medical Care AG (07/04/2026)